Lifeway Foods posts sales, margin and EPS gains; monetizes stake, buys herd for milk supply

Snapshot - Lifeway Foods, Inc. (NASDAQ: LWAY)

What's happening inside: Lifeway is growing top-line volume in its core drinkable kefir business, investing in marketing and capacity, monetized an equity stake (Simple Mills) which materially boosted six‑month other income, and is taking steps to secure organic milk supply (buying a herd and entering a herd-management agreement). The company remains debt-light with a strong cash balance and an unused $25.0M revolver.

Key facts & metrics (as reported)
- Net sales Q2 2025: $53,901k, up 9.7% vs Q2 2024 ($49,157k).
- Net sales 6M 2025: $99,992k, up 6.6% vs 6M 2024 ($93,791k).
- Gross profit Q2 2025: $15,400k (28.6% margin) vs $13,275k (27.0%).
- Net income Q2 2025: $4,249k; EPS (diluted) $0.28 vs Q2 2024 $3,783k; EPS $0.25/$0.26.
- Net income 6M 2025: $7,789k; EPS (diluted) $0.51 vs 6M 2024 $6,209k; EPS $0.41/$0.42.
- Cash & equivalents: $21,220k (June 30, 2025) vs $16,728k (Dec 31, 2024).
- Total assets: $98,267k; Total liabilities: $19,571k; Stockholders' equity: $78,696k (June 30, 2025).
- Accounts receivable: $16,065k; Inventories: $10,224k (up vs $8,678k).
- Operating cash flow 6M 2025: $3,762k (down from $8,090k in 6M 2024).
- Proceeds from sale of investment (Simple Mills): $5,206k; Gain recognized 6M 2025: $3,407k.
- Capital expenditures 6M 2025: $4,526k (growth/capacity & facility improvements).
- Revolving credit facility available: $25,000k; outstanding borrowings: $0 at June 30, 2025.
- Shares outstanding (Aug 6, 2025): 15,226,520.

Positive aspects of the income statement
- Revenue growth: solid volume-led sales gains in branded drinkable kefir (comparable sales growth ~18% in Q2 when adjusting certain 2024 distortions).
- Margin expansion: gross margin improved to 28.6% in Q2 (higher branded volumes, manufacturing leverage and favorable conventional milk pricing partially offset organic milk headwinds).
- Profitability: higher net income and EPS year-over-year for both quarter and six-month periods.
- One-time monetization: $3.4M gain on sale of investment materially boosted six-month other income and cash from investing activities.

Negative aspects / risks reflected in the income statement
- Rising operating spend: Selling expenses and G&A increased meaningfully (selling +$1.14M Q2 YoY; selling +$2.14M 6M YoY) as the company ramps marketing and incurred non-routine professional fees (shareholder activity / unsolicited bid response), pressuring operating income growth.
- Cash flow softness: operating cash flow fell to $3.76M in 6M 2025 from $8.09M, showing working capital and cash-earnings timing strain despite reported net income growth.
- Commodity pressure: organic milk pricing weighed on gross margin although partially offset by conventional milk and scale benefits - exposure remains.
- Customer concentration: two customers accounted for ~25% of net sales (3-6M periods), concentration risk remains material.
- Investment volatility / non-recurring items: six-month results benefited from a large investment gain; excluding that, operating income and cash generation are less strong.
- Stock-based and non-deductible compensation impacted effective tax rate and expense dynamics.

Operational & strategic notes
- Vertical supply move: July 2025 herd purchase (224 cows for $694k) and a 39‑month herd management agreement aim to secure organic milk supply - could reduce future input volatility but requires capital and still under accounting assessment.
- Capacity & capex: PP&E net increased to $30.7M (construction in progress rose to $5.46M); capex run-rate shows focus on growth/cost reduction.
- Balance sheet: low leverage (no revolver borrowings), strong liquidity cushion with $21.2M cash and $25M revolver availability; covenants in place and company in compliance.

What to watch next
- Organic milk pricing and whether herd strategy reduces cost volatility or adds complexity to financials; accounting treatment update for herd purchase.
- Marketing ROI: whether higher selling spend converts to sustained volume and margin gains.
- Operating cash flow recovery and working capital trends (inventory up and AR levels).
- Customer concentration mitigation - retention or diversification away from top two customers.
- Any further asset sales or one-time items that materially affect GAAP results.

Bottom line: Lifeway is executing growth initiatives in its core kefir franchise, translating volume gains into better gross margins and higher EPS, while using a one-time investment monetization to bolster cash. Key near-term challenges are higher operating expenses, reduced operating cash flow, organic milk cost pressure and customer concentration. The balance sheet is solid and the company has liquidity to fund its plans, but investors should separate recurring operating performance from one-time gains when assessing momentum.